Primary hyperparathyroidism is a common disease but 90% of sufferers r
emain undetected. In elderly women its prevalence is about 1%, The dis
ease can cause severe hypercalcaemia and lead to life-threatening symp
toms, However, the majority of cases represent milder forms of hyperpa
rathyroidism with minimal symptoms or no symptoms at all, and slight h
ypercalcaemia which does not progress during follow-up, Surgery is the
only effective treatment of primary hyperparathyroidism and most of t
he symptoms respond favourably to surgery, Nevertheless, the role of s
urgery has been controversial in the treatment of minisymptomatic pati
ents, Recently it has become evident that primary hyperparathyroidism
is associated with increased mortality due mainly to cardiovascular di
seases, and it has been shown that surgical treatment is able to dimin
ish or even eliminate this risk of premature death, The extra mortalit
y is connected also to the mild and nonprogressive forms of the diseas
e, and it seems to have a strong correlation with the duration of the
disease, This aspect favours active treatment at an early stage of the
disease, Conservative treatment can be considered only in old patient
s with mild and stable clinical course, Primary hyperparathyroidism is
an important risk factor causing morbidity and mortality.